SLC30A9 and cervical cancer: Furthermore, ChIP analysis in human tissues, using two distant primer pairs (Primer Pair #1 and Primer Pair #2), demonstrated that the binding activity of PRDM1 to the SLC30A9 promoter region was significantly elevated in cervical cancer tissues compared to adjacent normal cervical tissues (Fig. 7G).